Coppell Advisory Solutions LLC Has $4.16 Million Stake in McKesson Corporation $MCK

Coppell Advisory Solutions LLC lowered its position in shares of McKesson Corporation (NYSE:MCK) by 15.0% during the second quarter, Holdings Channel.com reports. The firm owned 5,733 shares of the company’s stock after selling 1,011 shares during the quarter. Coppell Advisory Solutions LLC’s holdings in McKesson were worth $4,161,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in MCK. Solstein Capital LLC lifted its holdings in shares of McKesson by 171.4% during the second quarter. Solstein Capital LLC now owns 38 shares of the company’s stock worth $28,000 after buying an additional 24 shares in the last quarter. State of Wyoming bought a new position in McKesson during the second quarter worth about $29,000. GFG Capital LLC acquired a new stake in McKesson in the 2nd quarter worth about $30,000. Saudi Central Bank bought a new stake in McKesson in the 1st quarter valued at about $34,000. Finally, Delos Wealth Advisors LLC acquired a new position in shares of McKesson during the 2nd quarter worth approximately $35,000. 85.07% of the stock is currently owned by institutional investors.

McKesson Stock Down 0.2%

Shares of MCK stock opened at $814.16 on Friday. The business has a fifty day simple moving average of $820.19 and a 200 day simple moving average of $748.31. The company has a market cap of $100.49 billion, a P/E ratio of 25.34, a P/E/G ratio of 1.34 and a beta of 0.38. McKesson Corporation has a twelve month low of $558.13 and a twelve month high of $895.58.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, November 5th. The company reported $9.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.84 by $1.02. The firm had revenue of $103.15 billion for the quarter, compared to analysts’ expectations of $103.80 billion. McKesson had a negative return on equity of 248.14% and a net margin of 1.04%.The business’s revenue for the quarter was up 10.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $7.07 earnings per share. As a group, equities research analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be given a $0.82 dividend. The ex-dividend date is Monday, December 1st. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 10.21%.

Insider Buying and Selling at McKesson

In other news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the company’s stock in a transaction on Friday, November 7th. The shares were sold at an average price of $861.63, for a total transaction of $283,476.27. Following the completion of the transaction, the chief accounting officer directly owned 328 shares in the company, valued at approximately $282,614.64. This represents a 50.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.08% of the company’s stock.

Analysts Set New Price Targets

MCK has been the subject of several recent research reports. Jefferies Financial Group boosted their price target on McKesson from $820.00 to $900.00 and gave the company a “buy” rating in a research note on Monday, October 13th. Robert W. Baird upped their target price on McKesson from $873.00 to $927.00 and gave the company an “outperform” rating in a research report on Thursday, November 6th. Wells Fargo & Company raised their price target on McKesson from $816.00 to $914.00 and gave the stock an “equal weight” rating in a research report on Monday, November 10th. UBS Group upped their price objective on shares of McKesson from $920.00 to $980.00 and gave the stock a “buy” rating in a research report on Thursday, November 6th. Finally, Zacks Research lowered shares of McKesson from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 25th. Two analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, McKesson has an average rating of “Moderate Buy” and a consensus target price of $892.86.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.